Search Results 1931-1940 of 19654 for hemoglobin

  1. Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA - Mayo Clinic

    Participation eligibility · MDS classified as follows: · At least one cytopenia (ANC < 1800/µL or platelet count < 100,000/µL or hemoglobin [Hgb] < 10 g/dL) ...

  2. Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States - Mayo Clinic

    Hemoglobin \<10 g/dL 3. Albumin \<3.0 g/dL 4. Prolonged international normalized ratio (INR) \>1.5 5. Total bilirubin ≥ 2.0 mg/dl (unless due to Gilbert's ...

  3. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    Hemoglobin ≥ 9 g/dL (may have been transfused);; Total serum bilirubin ≤ 1.5 times upper limit of normal (ULN);; Aspartate aminotransferase (AST/serum ...

  4. A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Hemoglobin ≥ 9 g/dL;; ANC ≥ 1.5 x 10^9/L;; Platelet count ≥ 75 x 10^9/L. Serum creatinine ≥ ULN; or estimated creatinine clearance ≥ 50 mL/min by ...

  5. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Hemoglobin ≥.0 g/dL;; Serum total bilirubin ≤.5× ULN or ≤× ULN for subjects with Gilbert's disease;; ALT and AST ≤× ULN (≤× ULN if evidence of hepatic ...

  6. Safusidenib Phase 2 Study In IDH1 Mutant Glioma - Mayo Clinic

    - Hemoglobin: ≥ 9.0 g/dL - Creatinine clearance (Cockcroft-Gault Formula) ≥ 60 mL/min An out-of-range laboratory test will be repeated up to 2 times ...

  7. Celiac disease - Diagnosis and treatment - Mayo Clinic

    This includes levels of vitamins A, B-12, D and E, as well as mineral levels, hemoglobin and liver enzymes. Your bone health also may be checked with a bone ...

  8. Neurology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  9. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    High risk (formerly Rai stage III/IV) is defined by lymphocytosis with or without enlarged nodes and spleen plus disease-related anemia (hemoglobin < 11 g ...

  10. Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF - Mayo Clinic

    Anemia (hemoglobin < 9.5 g/dL); c. Serum copper or ceruloplasmin below the normal reference range; d. Serologic evidence of Hepatitis B based on hepatitis B ...